NeuroFore: Revolutionizing Early Parkinson’s Diagnosis with AI
Biotech Healthcare HealthTech Business Technology 2 Minutes
NeuroFore is a biotechnology startup based in St. Louis, Missouri, dedicated to revolutionizing the early diagnosis of Parkinson’s disease through artificial intelligence. By focusing on non-motor symptoms that precede traditional motor indicators, NeuroFore aims to enable earlier interventions, significantly improving patient outcomes and reducing healthcare costs.
Why They Stand Out
NeuroFore distinguishes itself by targeting Parkinson’s disease at its earliest stages through subtle non-motor symptoms such as sleep disturbances, olfactory loss, and mood changes symptoms that typically appear years before motor impairments. Their AI-driven diagnostic tool provides a non-invasive, accurate, and scalable solution, positioning NeuroFore as a pioneer in the field of neurological diagnostics.
Why Watch
Despite being relatively new, NeuroFore has achieved notable early milestones:
-
Hult Prize Semifinalist: Recognized among thousands of global teams for their innovative approach and social impact potential.
-
Skandalaris Venture Competition Semifinalist: Demonstrated strong early traction, validating their innovative approach and business potential.
These early successes highlight NeuroFore’s potential to significantly influence the future of neurodegenerative disease diagnosis.
Meet the Team
-
Hamasa Ebadi -Founder and CEO at NeuroFore, leveraging her background in neuroscience and bioethics to lead research on early Parkinson’s detection through AI-powered neurodiagnostics.
-
Joseph Hess: Business Strategy Team Lead at NeuroFore, combining expertise in business, computer science, and psychology to drive strategic growth.
-
Evan (Yuwen) Tan: Communications Lead, skilled in developing innovative outreach strategies to effectively engage diverse stakeholders.
WOWS Take
With significant whitespace in early-stage Parkinson’s diagnostics, NeuroFore’s innovative use of artificial intelligence to detect non-motor symptoms is set to become a game changer in neurodegenerative care. Their early recognition in prestigious competitions, paired with a visionary team and promising technological approach, make them one of the most exciting emerging biotech startups in the market today.
Want to be part of the future of AI-driven healthcare?
Check out NeuroFore's profile on WOWS Global’s Deal Flow platform and discover other groundbreaking startups shaping the future of medicine.
Related Posts
-
Healthcare HealthTech SEA Biotech Southeast Asia 7 Minutes
Zafar VC: Powering Southeast Asia’s Healthcare Renaissance
With a RM1 billion fund dedicated to healthtech, biotech, and medtech, Zafar VC is reshaping Southeast Asia’s healthcare landscape. Backed by a multidisciplinary team and public–private partnerships, Zafar supports mission-driven founders from seed to scale, starting with companies like Pathomics Health. -
B2B AI Business Innovation Global-Asia Innovation 3 Minutes
SalesMind AI: Automating B2B Sales with Deep Tech Innovation
SalesMind AI is rewriting the rules of B2B sales by eliminating manual prospecting and enabling scalable, hyper-personalized outreach. With deep-tech intelligence and early market traction, it’s a game-changer for sales teams and a golden opportunity for investors. -
Southeast Asia MENA Investment Fintech HealthTech 4 Minutes
July 2025 Investment Snapshot: Southeast Asia & MENA
From fintech surges to deeptech breakthroughs, July 2025 delivered a wave of standout deals across Southeast Asia and MENA. This snapshot covers the top funding rounds, rising sectors, and the investors fueling growth across two of the world’s most dynamic startup ecosystems. -
AI Enterprise Automation Business 3 Minutes
iGOT.AI: The No-Code AI Platform Powering the Next Wave of Enterprise Automation
iGOT.AI is a no-code AI platform enabling businesses to deploy virtual AI employees that automate up to 80% of workflows. With strong early traction and a scalable model, it’s quickly emerging as a leader in the enterprise AI revolution. -
B2B eCommerce Stock Business Investment 3 Minutes
Liquid8: Powering Recommerce for Indonesia’s E-commerce Economy
Liquid8 is Indonesia’s first ESG-driven recommerce platform turning e-commerce returns and excess stock into profitable inventory for MSMEs. Founded by logistics veterans, the startup blends sustainability with scale—recycling over 2,100 tons of goods in under a year. Backed by SPIL Ventures, Liquid8 is redefining how Southeast Asia manages waste, returns, and small business growth. -
Digital Marketing Business Indonesia Innovation Entrepreneurship 3 Minutes
Dolan: Pioneering Indonesia’s Digital Travel Marketplace
Dolan is an Indonesian travel-tech startup offering a digital marketplace that connects global travelers with authentic local experiences and businesses. By enabling local tourism providers to reach a wider audience, Dolan opens Indonesia’s destinations to global travelers and helps drive the country’s tourism growth. As Indonesia's tourism rebounds, Dolan’s scalable model and mission to empower local businesses position it for significant growth, attracting strong investor interest.